title: [Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
authors.forename: S
authors.initials: S
authors.lastname: Odagiri
authors.forename: Y
authors.initials: Y
authors.lastname: Watanuki
authors.forename: H
authors.initials: H
authors.lastname: Takahashi
authors.forename: J
authors.initials: J
authors.lastname: Shimada
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002511:Cephalosporins / Q000008:administration & dosage; D002908:Chronic Disease; D017291:Clarithromycin / Q000008:administration & dosage; D017714:Community-Acquired Infections; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007769:Lactams; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000302:isolation & purification*; D013997:Time Factors; D047090:beta-Lactams
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D007769:Lactams; D047090:beta-Lactams; C073460:cefditoren; D015242:Ofloxacin; C107057:fropenem; D017291:Clarithromycin